Pharmaceutical research: set the pace for innovation
Faster from the lab to clinical trials to market: With a set of aligned solutions, you can streamline your pharmaceutical research processes
It takes years to discover a new drug. The preclinical phase and afterwards the clinical phase might last for up to 12 years and maybe more. So it's time to focus on how to improve your efficiency in your pharmaceutical research and development processes. No more laborious tracking of lab tests and results, no more trial-and-error approaches to recipe and process design, no more time-consuming compilation of data for records and documentation. Utilize the latest digital solutions to enable seamless transition of lab data and recipes to production by integrating R&D with process and product development to win the race against time.
Speeding up process and product design
Utilize the latest digital solutions to enable seamless transition of lab data and recipes to production by integrating R&D with process and product development to win the race against time. The pharmaceutical industry has always been subject to stringent monitoring and regulations – but in recent years, the pressure from the authorities as well as a shift in market requirements has led to significant changes in the way new drugs are being developed and produced. Both the approval of the new drug and the manufacturing process need to be developed in parallel, and the production equipment must be flexible enough to produce changing amounts of one product or several different products or, ideally, both.
Co-evolving drugs and the manufacturing processes also helps shorten the time-to-market, as larger amounts of drugs can be made earlier, and the experience gained from the small-scale process can be more easily scaled up to meet commercial production requirements. We help you integrate the various sources of data along the critical stages of pre-clinical testing from clinical trials to industrialization.
Building a digital twin with advanced modelling
With the digital twin concept, we are able to use different technologies to create a virtual world in which the research and development for new therapies and vaccines can be accelerated. To speed it up we established a new Siemens Business with Process Systems Enterprise (PSE) that enables to optimize your plant’s productivity and performance using predictive models that faithfully reflect the real thing.
For example, a new process can be modeled with gPROMS software and extensively tested and simulated. With the help of our complete multiphysics simulation solution STAR-CCM+ it becomes possible to simulate the material flow within a bioreactor.
LivingLab Vienna: Pharmaceutical research boosted by digitalization
The LivingLab at the Siemens City in Vienna is the place where visionary ideas are tested under realistic conditions and developed further for your production. It also showcases Austria’s strong industry and research expertise in the field of bioprocesses. The focus is on all industries that manufacture entire batches rather than individual components, in particular the pharmaceutical industry, the food & beverage industry, and the chemical industry. industrialization.
Individualized production in Pharma
The future of pharmaceutical care lies in individual drugs that are tailored to the genome of small patient groups or even a single patient. Via a digital twin, individualized drugs can be produced fast, compliant, affordable and in high-quality.
